| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −1.8× | −1.8× | |
| Price / Book | 1.9× | 2.1× | |
| Price / Sales | — | 4.0× | — |
| Price / Free cash flow | −2.0× | −1.6× | |
| EV / EBITDA | −0.8× | −1.2× | |
| Earnings yield | −57.0% | −14.0% | |
| Free cash flow yield | −49.6% | −9.5% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,281.60 | −1.92% | $1.21T | 59.6× | 77.8% | +21.1% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $262.96 | −1.74% | $633.03B | 24.0× | 32.9% | +39.5% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $284.96 | −0.08% | $503.56B | 119.3× | −129.2% | +23.3% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $423.79 | −0.28% | $380.39B | 31.6× | 12.8% | +16.3% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.85 | −1.62% | $357.37B | 19.9× | 34.7% | +68.0% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.84 | −3.47% | $271.81B | 20.0× | 30.5% | +19.0% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $171.47 | −0.64% | $265.93B | 26.1× | 21.1% | +3.3% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $667.50 | −1.34% | $246.81B | 37.1× | 12.6% | +21.2% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $442.55 | −1.06% | $239.26B | 31.4× | 89.1% | +48.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.92 | −0.17% | $194.57B | 22.9× | 37.5% | +26.7% |
